SCHEMBL7599205

SCHEMBL7599205

NCCCC(N)(C(N)CN)C(N)CCN

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ODC1 P11926 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11523018 0.75 ODC1 (0.33) ODC1
SCHEMBL15401090 0.73 ODC1 (0.32) ODC1
SCHEMBL9353966 0.67 GSR (0.30)
SCHEMBL995528 0.67 DNM1 (0.35)
SCHEMBL4920072 0.65 ODC1 (0.33) ODC1
SCHEMBL166120 0.65
SCHEMBL3693584 0.64
SCHEMBL10768572 0.64
SCHEMBL10881994 0.63
SCHEMBL27863382 0.62 NFKB1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261620-A2 CATIONIC AMPHIPHILES FOR USE IN NUCLEIC ACID TRANSFECTION Roche Diagnostics Corporation (US) 2002-12-04 EP disclosed
WO-2001057064-A2 CATIONIC AMPHIPHILES FOR USE IN NUCLEIC ACID TRANSFECTION ROCHE DIAGNOSTICS CORPORATION (US) 2001-08-09 WO disclosed